Mohammad Yasin Karami
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mohammad Yasin Karami has a total of 154 co-authors. Here are the top co-authors by number of shared publications:
- Alireza Makarem
Department of Urology, Shiraz University of Medical Sciences, Shiraz 7134846114, Iran
7 shared publications Aida Amanat
4 shared publications- Hassan Zabetian
Department of Anesthesiology, Jahrom University of Medical Sciences, Jahrom, Iran
4 shared publications Mina Alvandipour
Department of Colorectal Surgery, Mazandaran University of Medical Sciences, Sari, Iran
4 shared publications- Sedigheh Tahmasebi
Breast Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
4 shared publications Shahram Paydar
Trauma Research Center, Rajaee (Emtiaz) Trauma Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
4 shared publications
Latest Publications
- 6 May 2025
- Published by Index Copernicus in Polish Journal of Surgery
- Vol. 97 (4) , 35-43
The effectiveness of local steroid injection for the treatment of breast-limited idiopathic granulomatous mastitis: A randomized controlled clinical trial study
Introduction: Idiopathic granulomatous mastitis (IGM) is a rare, non-specific inflammatory breast disease. There are severalcontroversies regarding its standard treatment.Aim: We aimed to evaluate the efficacy of local corticosteroid injection compared to systemic steroids and combined treatment of both in IGM patients.Methods: In this randomized controlled clinical trial study, 115 IGM patients were randomly allocated to three groups of localsteroid injection (Betamethasone, n = 37), systemic steroid treatment (Prednisolone + MTX, n = 37), or combined treatment ofboth (n = 41) for a follow-up period of 10 months. Clinical presentations and outcomes were compared between the groups.Results: The mean age of the study patients was 35.6 years. The mean time to complete remission was 3.17, 4.33, and 6.37 months, and the relapse rate during the treatment was 0%, 5.26%, and 13.33% in the injection, combined, and systemic therapy groups, respectively. There was no significant difference between the clinical response to treatment rate and the recurrence rate during the follow-up between the groups. Four patients in the combined therapy group and 3 patients in the systemic therapy group had steroid side effects, with no side effects in the injection group.Conclusions: Steroid injection therapy is more effective than combined therapy and systemic therapy in terms of remission and relapse rate during the treatment, and is as effective as systemic therapy in the clinical response to treatment rate and the recurrence rate during the follow-up period. Regarding the lack of side effects of the steroid injection therapy, this approach could be considered among the first-line treatment options.
- 6 May 2025
- Published by Index Copernicus in Polish Journal of Surgery
- Vol. 97 (4) , 35-43
The effectiveness of local steroid injection for the treatment of breast-limited idiopathic granulomatous mastitis: A randomized controlled clinical trial study
Introduction: Idiopathic granulomatous mastitis (IGM) is a rare, non-specific inflammatory breast disease. There are severalcontroversies regarding its standard treatment.Aim: We aimed to evaluate the efficacy of local corticosteroid injection compared to systemic steroids and combined treatment of both in IGM patients.Methods: In this randomized controlled clinical trial study, 115 IGM patients were randomly allocated to three groups of localsteroid injection (Betamethasone, n = 37), systemic steroid treatment (Prednisolone + MTX, n = 37), or combined treatment ofboth (n = 41) for a follow-up period of 10 months. Clinical presentations and outcomes were compared between the groups.Results: The mean age of the study patients was 35.6 years. The mean time to complete remission was 3.17, 4.33, and 6.37 months, and the relapse rate during the treatment was 0%, 5.26%, and 13.33% in the injection, combined, and systemic therapy groups, respectively. There was no significant difference between the clinical response to treatment rate and the recurrence rate during the follow-up between the groups. Four patients in the combined therapy group and 3 patients in the systemic therapy group had steroid side effects, with no side effects in the injection group.Conclusions: Steroid injection therapy is more effective than combined therapy and systemic therapy in terms of remission and relapse rate during the treatment, and is as effective as systemic therapy in the clinical response to treatment rate and the recurrence rate during the follow-up period. Regarding the lack of side effects of the steroid injection therapy, this approach could be considered among the first-line treatment options.
- Open Access
- 20 October 2023
- Published by Academic World Research in Medical Journal of the Islamic Republic Of Iran
- Vol. 37 (1) , 892-895
Breast Cancer Survivors and COVID-19: Prevalence and Risk of Severe Disease in a Screening Study
Background: Determining the risk of severe course coronavirus disease 2019 (COVID-19) and its related factors in survivors of common cancers such as breast cancer is important. This study has been designed to evaluate the prevalence of COVID-19 infection in breast cancer survivors and also estimate the risk of severe disease ...
- 20 October 2023
- Published by Academic World Research in Medical Journal of the Islamic Republic Of Iran
- Vol. 37 (1) , 892-895
Open AccessBreast Cancer Survivors and COVID-19: Prevalence and Risk of Severe Disease in a Screening Study
Background: Determining the risk of severe course coronavirus disease 2019 (COVID-19) and its related factors in survivors of common cancers such as breast cancer is important. This study has been designed to evaluate the prevalence of COVID-19 infection in breast cancer survivors and also estimate the risk of severe disease ...
- Open Access
- 3 December 2022
- Published by Springer Nature in European Journal of Medical Research
- Vol. 27 (1) , 1-9
Comparison of volatile/inhalational and IV anesthesia in long-term survival of patients with breast cancer: a retrospective study
Objective: Breast cancer is a worldwide health concern, and surgical removal has remained the preferred therapeutic option in most patients. Furthermore, the current study was designed to investigate the disease-free survival and overall survival in breast cancer patients, who receive either propofol or isoflurane during operation. Method: This retrospective study was conducted on 994 patients (IV group, n = 530; volatile/inhalational group, n = 464) who underwent breast cancer operation from January 2006 to December 2016 at Faghihi Hospital, Shiraz, Iran. All studied patients were followed up till 2020. Patients are classified into two groups, IV and volatile/inhalational, according to the received anesthesia. For statistical analysis, The Cox regression test was conducted to investigate the association between factors affecting the recurrence of the disease and the Log Rank test was utilized to assess the patients’ survival. Finally, to reduce the effect of confounding factors, all patients were matched according to age, tumor size and tumor grade. Results: Based on results from the log-rank test, the volatile/inhalational group had a better recurrence-free survival (P = 0.039) compared to the total IV group. However, the overall survival was not considerably different (P = 0.520). Conclusion: The current study showed that although 2-year disease-free survival is higher in the volatile/inhalational group, there is no meaningful association between the 5-year overall survival and anesthesia technique.
- 3 December 2022
- Published by Springer Nature in European Journal of Medical Research
- Vol. 27 (1) , 1-9
Open AccessComparison of volatile/inhalational and IV anesthesia in long-term survival of patients with breast cancer: a retrospective study
Objective: Breast cancer is a worldwide health concern, and surgical removal has remained the preferred therapeutic option in most patients. Furthermore, the current study was designed to investigate the disease-free survival and overall survival in breast cancer patients, who receive either propofol or isoflurane during operation. Method: This retrospective study was conducted on 994 patients (IV group, n = 530; volatile/inhalational group, n = 464) who underwent breast cancer operation from January 2006 to December 2016 at Faghihi Hospital, Shiraz, Iran. All studied patients were followed up till 2020. Patients are classified into two groups, IV and volatile/inhalational, according to the received anesthesia. For statistical analysis, The Cox regression test was conducted to investigate the association between factors affecting the recurrence of the disease and the Log Rank test was utilized to assess the patients’ survival. Finally, to reduce the effect of confounding factors, all patients were matched according to age, tumor size and tumor grade. Results: Based on results from the log-rank test, the volatile/inhalational group had a better recurrence-free survival (P = 0.039) compared to the total IV group. However, the overall survival was not considerably different (P = 0.520). Conclusion: The current study showed that although 2-year disease-free survival is higher in the volatile/inhalational group, there is no meaningful association between the 5-year overall survival and anesthesia technique.
- Open Access
- 23 March 2022
- Published by Springer Nature in Research Square
The effectiveness of local steroid injection for the treatment of breast-limited idiopathic granulomatous mastitis: A randomized controlled clinical trial study
Background: Idiopathic granulomatous mastitis (IGM) is a rare non-specific inflammatory breast disease and is usually considered a kind of autoimmune disease. There are several controversies regarding its standard treatment. We aimed to evaluate the efficacy of local corticosteroid injection for the treatment of breast-limited idiopathic granulomatous mastitis.Methods: This randomized prospective clinical trial study evaluated the clinical response rate of local steroid injection to treat breast-limited IGM in women. The subjects received local steroid injection of long-action (LA) Betamethasone combined with standard systemic treatments (prednisolone, Methotrexate) (Combine therapy group), standard systemic treatments alone (Systemic group), or local steroid injection alone (LA Betamethasone, Injection group). Clinical benefits and recurrence rates were compared in the three groups.Results: All of the patients were women, and their mean age was 34 years. The excellent clinical or radiological response was observed in 20/31 (64.5%), 24/38 (63.1%), and 17/30 (56.6 %) patients in the injection, combined, and systemic therapy groups, respectively. During the follow-up of 10 months in patients who received local steroid injection alone, recurrence was observed in six patients (16.4%, 6/31), and no side effects or injection steroid-related complications occurred. The local recurrence rate in systemic and combined therapy groups were 3.3 % (1/30) and 13.2 % (5/38) patients, respectively.Conclusions: Our findings suggest that local betamethasone LA injection in breast limited IGM is as successful as current standard treatment and shortens the complete healing time compared to treatment with systemic therapy. Short time recurrence rate was not statistically significant among the groups. Local injection could be a beneficial option in the treatment of IGM. Trial registration: The trial registry number was IRCT20200608047694N1. Registration date: 2020-07-21.
- 23 March 2022
- Published by Springer Nature in Research Square
Open AccessThe effectiveness of local steroid injection for the treatment of breast-limited idiopathic granulomatous mastitis: A randomized controlled clinical trial study
Background: Idiopathic granulomatous mastitis (IGM) is a rare non-specific inflammatory breast disease and is usually considered a kind of autoimmune disease. There are several controversies regarding its standard treatment. We aimed to evaluate the efficacy of local corticosteroid injection for the treatment of breast-limited idiopathic granulomatous mastitis.Methods: This randomized prospective clinical trial study evaluated the clinical response rate of local steroid injection to treat breast-limited IGM in women. The subjects received local steroid injection of long-action (LA) Betamethasone combined with standard systemic treatments (prednisolone, Methotrexate) (Combine therapy group), standard systemic treatments alone (Systemic group), or local steroid injection alone (LA Betamethasone, Injection group). Clinical benefits and recurrence rates were compared in the three groups.Results: All of the patients were women, and their mean age was 34 years. The excellent clinical or radiological response was observed in 20/31 (64.5%), 24/38 (63.1%), and 17/30 (56.6 %) patients in the injection, combined, and systemic therapy groups, respectively. During the follow-up of 10 months in patients who received local steroid injection alone, recurrence was observed in six patients (16.4%, 6/31), and no side effects or injection steroid-related complications occurred. The local recurrence rate in systemic and combined therapy groups were 3.3 % (1/30) and 13.2 % (5/38) patients, respectively.Conclusions: Our findings suggest that local betamethasone LA injection in breast limited IGM is as successful as current standard treatment and shortens the complete healing time compared to treatment with systemic therapy. Short time recurrence rate was not statistically significant among the groups. Local injection could be a beneficial option in the treatment of IGM. Trial registration: The trial registry number was IRCT20200608047694N1. Registration date: 2020-07-21.
- 17 November 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 138-143
AutoEncoder-based Safe Reinforcement Learning for Power Augmentation in a Lower-limb Exoskeleton
Power augmentation in wearable robots has recently attracted the attention of researchers in industry and academia. Human-robot synchronized control is one of the most substantial goals that needs to be achieved. The change of gait patterns between different users and cycles, and the close interaction of human and robot necessitates the estimation of human motion intention in real-time. Reinforcement learning (RL) is beneficial in such situations mainly due to its online and model-free nature. However, RL algorithms struggle in high-dimensional continuous search spaces in terms of convergence speed and safety. Therefore, this paper proposes an RL-based control strategy for power augmentation in a lower-limb exoskeleton to extract the human motion and minimize the interaction force. A deep AutoEncoder (AE) neural network is trained and employed for dimensionality reduction to improve the convergence speed and safety. Simulation and two experiments were carried out with a lower-limb exoskeleton on a healthy participant. The results indicate the efficacy of the proposed control strategy and its superior performance compared to model-based approaches while improving speed and safety.
- 17 November 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 138-143
AutoEncoder-based Safe Reinforcement Learning for Power Augmentation in a Lower-limb Exoskeleton
Power augmentation in wearable robots has recently attracted the attention of researchers in industry and academia. Human-robot synchronized control is one of the most substantial goals that needs to be achieved. The change of gait patterns between different users and cycles, and the close interaction of human and robot necessitates the estimation of human motion intention in real-time. Reinforcement learning (RL) is beneficial in such situations mainly due to its online and model-free nature. However, RL algorithms struggle in high-dimensional continuous search spaces in terms of convergence speed and safety. Therefore, this paper proposes an RL-based control strategy for power augmentation in a lower-limb exoskeleton to extract the human motion and minimize the interaction force. A deep AutoEncoder (AE) neural network is trained and employed for dimensionality reduction to improve the convergence speed and safety. Simulation and two experiments were carried out with a lower-limb exoskeleton on a healthy participant. The results indicate the efficacy of the proposed control strategy and its superior performance compared to model-based approaches while improving speed and safety.
- Open Access
- 1 April 2021
- Published by Maad Rayan Publishing Company in International Journal of Infectious Diseases
- Vol. 24 (4) , 289-295
Surgical Management of Intestinal Failure; Initial Experiences from an Intestinal Failure, Rehabilitation and Transplant Unit in Iran
Background: Intestinal failure (IF) is a life-threatening medical condition. The management of IF in low- and middle-income countries without home parenteral nutrition (HPN) remains unclear. We recently established an intestinal rehabilitation unit (IRU) and aimed to provide our experience on the current management and outcomes of IF in Iran. Methods: In this cross-sectional case series, data were collected from an established database on IF in the Shiraz Transplant Center in Abu Ali Sina hospital, affiliated to Shiraz University of Medical Sciences, Iran from January 2018 to October 2018. Results: Overall, 30 patients with a mean age of 44.13 ± 10.32 years, which included 25 males, were recruited. Short bowel syndrome (SBS) (60%) and enterocutaneous fistulae (27%), as complication of previous surgeries, were the main causes of IF. The most common type of IF was type 3 (67 %). Mesenteric ischemia was the leading mechanism of IF (47%). Fifteen patients (50%) received autologous gastrointestinal reconstruction surgery (AGIRS), and two (7%) patients had serial transverse enteroplasty (STEP). At the end of follow-up, 15 patients recovered from IF (50%). The overall survival rate was 83.3%. Conclusion: This series introduced the results of a multidisciplinary program for the treatment of IF in a middle-income country that lacks facilities for HPN. Our protocol of care, understanding the need for development of HPN, showed promising clinical outcomes.
- 1 April 2021
- Published by Maad Rayan Publishing Company in International Journal of Infectious Diseases
- Vol. 24 (4) , 289-295
Open AccessSurgical Management of Intestinal Failure; Initial Experiences from an Intestinal Failure, Rehabilitation and Transplant Unit in Iran
Background: Intestinal failure (IF) is a life-threatening medical condition. The management of IF in low- and middle-income countries without home parenteral nutrition (HPN) remains unclear. We recently established an intestinal rehabilitation unit (IRU) and aimed to provide our experience on the current management and outcomes of IF in Iran. Methods: In this cross-sectional case series, data were collected from an established database on IF in the Shiraz Transplant Center in Abu Ali Sina hospital, affiliated to Shiraz University of Medical Sciences, Iran from January 2018 to October 2018. Results: Overall, 30 patients with a mean age of 44.13 ± 10.32 years, which included 25 males, were recruited. Short bowel syndrome (SBS) (60%) and enterocutaneous fistulae (27%), as complication of previous surgeries, were the main causes of IF. The most common type of IF was type 3 (67 %). Mesenteric ischemia was the leading mechanism of IF (47%). Fifteen patients (50%) received autologous gastrointestinal reconstruction surgery (AGIRS), and two (7%) patients had serial transverse enteroplasty (STEP). At the end of follow-up, 15 patients recovered from IF (50%). The overall survival rate was 83.3%. Conclusion: This series introduced the results of a multidisciplinary program for the treatment of IF in a middle-income country that lacks facilities for HPN. Our protocol of care, understanding the need for development of HPN, showed promising clinical outcomes.
- Open Access
- 1 January 2021
- Vol. 12 (1) , 97-105
Clinicopathological Behavior of Mucinous Breast Carcinoma in South of Iran: The Shiraz Breast Cancer Registry
- 1 January 2021
- Vol. 12 (1) , 97-105
Open AccessClinicopathological Behavior of Mucinous Breast Carcinoma in South of Iran: The Shiraz Breast Cancer Registry
- Open Access
- 29 October 2020
- Vol. 34 (1) , 146
The effect of silicone gel versus contractubex gel on the upper-extremity postsurgical scars: A randomized, double-blinded, controlled trial
Background: Wound healing is a process that has three overlapping inflammatory, proliferative, and reconstruction phases. Silicone gel and Contractubex (onion extract gel) are two main topical agents used for the prevention and treatment of hypertrophic scars. This clinical trial study aimed to evaluate the efficacy and safety of onion extract and silicone gel on hypertrophic scars of the upper extremity and compare it to non-treated patients.
- 29 October 2020
- Vol. 34 (1) , 146
Open AccessThe effect of silicone gel versus contractubex gel on the upper-extremity postsurgical scars: A randomized, double-blinded, controlled trial
Background: Wound healing is a process that has three overlapping inflammatory, proliferative, and reconstruction phases. Silicone gel and Contractubex (onion extract gel) are two main topical agents used for the prevention and treatment of hypertrophic scars. This clinical trial study aimed to evaluate the efficacy and safety of onion extract and silicone gel on hypertrophic scars of the upper extremity and compare it to non-treated patients.
- Open Access
- 1 June 2020
- Published by Maad Rayan Publishing Company in International Journal of Infectious Diseases
- Vol. 23 (6) , 422-425
Guideline for Management of Mesenteric Ischemia: Shiraz Intestinal Failure Unit Protocol
We have recently established an intestinal rehabilitation unit (IRU) in Abu Ali Sina transplantation center affiliated to Shiraz University of Medical Sciences, Iran. Our intestinal failure rehabilitation and transplant program aims to provide state-of-the-art care for adult patients with different degrees of intestinal insufficiency and failure. In the IRU, we aimed to design an algorithmic approach to patients with small bowel ischemia and short bowel syndrome (SBS) based on our institutional experience in our country and based on other pioneering studies from other regions of the world.
- 1 June 2020
- Published by Maad Rayan Publishing Company in International Journal of Infectious Diseases
- Vol. 23 (6) , 422-425
Open AccessGuideline for Management of Mesenteric Ischemia: Shiraz Intestinal Failure Unit Protocol
We have recently established an intestinal rehabilitation unit (IRU) in Abu Ali Sina transplantation center affiliated to Shiraz University of Medical Sciences, Iran. Our intestinal failure rehabilitation and transplant program aims to provide state-of-the-art care for adult patients with different degrees of intestinal insufficiency and failure. In the IRU, we aimed to design an algorithmic approach to patients with small bowel ischemia and short bowel syndrome (SBS) based on our institutional experience in our country and based on other pioneering studies from other regions of the world.
- Open Access
- 20 May 2020
- Vol. 34, 50
Intraoperative radiation therapy in non-breast cancer patients: A report of 26 cases from Shiraz, south of Iran
Background: Intraoperative radiation therapy (IORT) is the delivery of radiation at the time of surgery. Whereas the dose delivered by external beam radiation therapy (EBRT) is limited by the tolerance of the surrounding normal tissues, IORT allows exclusion of a part or all of the dose-limiting sensitive structures by operative mobilization and/or direct shielding of these structures. The aim of the present study was to report the non-breast cancer patients' outcomes after receiving IORT in Shiraz, Iran.
- 20 May 2020
- Vol. 34, 50
Open AccessIntraoperative radiation therapy in non-breast cancer patients: A report of 26 cases from Shiraz, south of Iran
Background: Intraoperative radiation therapy (IORT) is the delivery of radiation at the time of surgery. Whereas the dose delivered by external beam radiation therapy (EBRT) is limited by the tolerance of the surrounding normal tissues, IORT allows exclusion of a part or all of the dose-limiting sensitive structures by operative mobilization and/or direct shielding of these structures. The aim of the present study was to report the non-breast cancer patients' outcomes after receiving IORT in Shiraz, Iran.